GOLDMAN SACHS GROUP INC

Position in PDSB — PDS Biotechnology Corp

CIK 886982 NEW YORK, NY

Position in PDSB

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,852

-$921,305 QoQ

Shares Held

10,048

-96.8% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#35

of 52 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. PDSB ranks #348 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,481,761	$1,232,765,138
2	REGN	Regeneron Pharmaceuticals, Inc.	1,163,191	$725,296,113
3	ROIV	Roivant Sciences Ltd.	18,556,458	$656,713,046
4	TECH	BIO-TECHNE Corp	7,343,324	$518,805,838
5	RVMD	Revolution Medicines, Inc.	2,133,101	$399,487,154
6	MRNA	Moderna, Inc.	4,671,950	$327,176,656
7	TNGX	Tango Therapeutics, Inc.	9,980,620	$311,994,180
8	INCY	Incyte Corp	2,305,782	$261,383,446

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,852	10,048	-96.8%	Shares	Defined	2026-08-14
2024-06-30	$930,157	317,460	+250.9%	Shares	Defined	2024-08-13
2024-03-31	$358,276	90,474	+624.6%	Shares	Defined	2024-05-15
2023-12-31	$62,055	12,486	-6.3%	Shares	Defined	2024-05-14
2023-09-30	$67,276	13,322	-51.9%	Shares	Defined	2024-05-15
2023-06-30	$139,320	27,698	-67.5%	Shares	Defined	2024-05-14
2023-03-31	$523,801	85,171	+186.3%	Shares	Defined	2024-05-14
2022-03-31	$184,164	29,752	-6.3%	Shares	Defined	2022-05-16
2021-12-31	$257,271	31,762	+178.7%	Shares	Defined	2022-02-17
2021-09-30	$169,785	11,395	-45.4%	Shares	Defined	2022-01-20
2021-03-31	$94,944	20,867	+6.5%	Shares	Defined	2021-05-17
2020-12-31	$41,944	19,600	—	Shares	Defined	2021-02-12
No filing history on record for this holder in this stock.